Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Herpes simplex virus type 1 reshapes host chromatin architecture via transcription machinery hijacking

  • González-Almela, Esther
  • Castells García, Àlvaro, 1991-
  • Le Dily, François
  • Fernández Merino, Manuel
  • Carnevali, Davide
  • Cuscó Pons, Pol, 1987-
  • Di Croce, Luciano
  • Cosma, Maria Pia
Herpes simplex virus type 1 (HSV-1) remodels the host chromatin structure and induces a host-to-virus transcriptional switch during lytic infection. We combine super-resolution imaging and chromosome-capture technologies to identify the mechanism of remodeling. We show that the host chromatin undergoes massive condensation caused by the hijacking of RNA polymerase II (RNAP II) and topoisomerase I (TOP1). In addition, HSV-1 infection results in the rearrangement of topologically associating domains and loops, although the A/B compartments are maintained in the host. The position of viral genomes and their association with RNAP II and cohesin is determined nanometrically. We reveal specific host-HSV-1 genome interactions and enrichment of upregulated human genes in the most contacting regions. Finally, TOP1 inhibition fully blocks HSV-1 infection, suggesting possible antiviral strategies. This viral mechanism of host chromatin rewiring sheds light on the role of transcription in chromatin architecture., We acknowledge support from Innovative Team Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR110103001 to M.P.C.); Guangzhou Key Projects of Brain Science and Brain-Like Intelligence Technology (20200730009 to M.P.C.); National Natural Science Foundation of China (31971177 and 32270577 to M.P.C., 3221101299 to A.C.G.); Science and Technology Program of Guangzhou, China (202002030146 to M.P.C.); Guangdong Foreign Young Talent Program (WGZJXM04 to A.C.G.); Spanish Ministry of Science and Innovation (grant no. PID2020-114080GB I00/AEI/10.13039/501100011033 and grant no. BFU2017-86760-P/AEI/FEDER, UE to M.P.C.) and an AGAUR grant from the Department of Research and Universities of Generalitat de Catalunya (2021-SGR2021-01300 to M.P.C.); Spanish Ministry of Science and Innovation to the European Molecular Biology Laboratory (EMBL) partnership (to M.P.C.); the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN?AEI /10.13039/501100011033); European Social Fund (FI_B00103 to M.F.M.). Funding for open access charge: National Natural Science Foundation of China (NSFC) grant (3221101299 to A.C.G.).; Spanish Ministry of Economy, Industry and Competitiveness (PID2019-108322GB-100 to L.D.C.).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

SMARCAD1 and TOPBP1 contribute to heterochromatin maintenance at the transition from the 2C-like to the pluripotent state

  • Sebastián Pérez, Rubén
  • Nakagawa, Shoma
  • Tu, Xiaochuan
  • Aranda Aragón, Sergio
  • Pesaresi, Martina, 1991-
  • Gómez García, Pablo
  • Alcoverro-Bertran, Marc
  • Gómez Vázquez, José Luis
  • Carnevali, Davide
  • Borràs, Eva
  • Sabidó Aguadé, Eduard, 1981-
  • Martin, Laura
  • Nissim Rafinia, Malka
  • Meshorer, Eran
  • Neguembor, Maria Victoria
  • Di Croce, Luciano
  • Cosma, Maria Pia
Chromocenters are established after the 2-cell (2C) stage during mouse embryonic development, but the factors that mediate chromocenter formation remain largely unknown. To identify regulators of 2C heterochromatin establishment, we generated an inducible system to convert embryonic stem cells (ESCs) to 2C-like cells. This conversion is marked by a global reorganization and dispersion of H3K9me3-heterochromatin foci, which are then reversibly formed upon re-entry into pluripotency. Profiling the chromatin-bound proteome (chromatome) by genome capture of ESCs transitioning to 2C-like cells, we uncover chromatin regulators involved in de novo heterochromatin formation. We identified TOPBP1 and investigated its binding partner SMARCAD1. SMARCAD1 and TOPBP1 associate with H3K9me3-heterochromatin in ESCs. Interestingly, the nuclear localization of SMARCAD1 is lost in 2C-like cells. SMARCAD1 or TOPBP1 depletion in mouse embryos lead to developmental arrest, reduction of H3K9me3 and remodeling of heterochromatin foci. Collectively, our findings contribute to comprehending the maintenance of chromocenters during early development., This work was supported by the European Union’s Horizon 2020 Research and Innovation Programme (No 686637 and No 964342 to MPC), Ministerio de Ciencia e Innovación (grant no. PID2020-114080GB I00/AEI/10.13039/501100011033 and grant no. BFU2017-86760-P/AEI/FEDER, UE to MPC), an AGAUR grant from the Departament de Recerca i Universitats de la Generalitat de Catalunya (2021-SGR2021-01300 to MPC), Fundació La Marató de TV3 (202027-10 to MPC), and National Natural Science Foundation of China (No 31971177 to MPC); Spanish Ministry of Economy, Industry and Competitiveness (MEIC) (PID2019-108322GB-100 to LDC), and from AGAUR (LDC). We acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme. The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I+D+i 2013–2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF. RS-P was supported by a FI-AGAUR PhD fellowship from the Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement de la Generalitat de Catalunya and the co-finance of Fondo Social Europeo (2018FI_B_00637 and FSE). XT is supported by an FPI PhD fellowship from the Ministerio de Ciencia e Innovación (PRE2018-085107). SA is funded by the Ramon y Cajal program of the Ministerio de Ciencia, Innovación y Universidades, and the European Social Fund under the reference number RYC-2018-025002-I, and the Instituto de Salud Carlos III-FEDER (PI19/01814). LM is supported by a grant for the recruitment of early-stage research staff FI-2020 (Operational Program of Catalonia 2014–2020 CCI grant no. 2014ES05SFOP007 of the European Social Fund) and La Caixa Foundation fellowship (LCF/BQ/DR20/11790016). MP was supported by a Severo Ochoa PhD fellowship from the Subprograma Estatal de Formación del Ministerio de Economía y Competitividad (BES-2015-072802). MVN is funded by FP7/2007–2013 under an REA grant (608959) and Juan de la Cierva-Incorporación 2017.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

SpikChIP: a novel computational methodology to compare multiple ChIP-seq using spike-in chromatin

  • Blanco, Enrique
  • Di Croce, Luciano
  • Aranda Aragón, Sergio
In order to evaluate cell- and disease-specific changes in the interacting strength of chromatin targets, ChIP-seq signal across multiple conditions must undergo robust normalization. However, this is not possible using the standard ChIP-seq scheme, which lacks a reference for the control of biological and experimental variabilities. While several studies have recently proposed different solutions to circumvent this problem, substantial analytical differences among methodologies could hamper the experimental reproducibility and quantitative accuracy. Here, we propose a computational method to accurately compare ChIP-seq experiments, with exogenous spike-in chromatin, across samples in a genome-wide manner by using a local regression strategy (spikChIP). In contrast to the previous methodologies, spikChIP reduces the influence of sequencing noise of spike-in material during ChIP-seq normalization, while minimizes the overcorrection of non-occupied genomic regions in the experimental ChIP-seq. We demonstrate the utility of spikChIP with both histone and non-histone chromatin protein, allowing us to monitor for experimental reproducibility and the accurate ChIP-seq comparison of distinct experimental schemes. spikChIP software is available on GitHub (https://github.com/eblancoga/spikChIP)., Spanish of Economy, Industry and Competitiveness (MEIC) (BFU2016-75008-P, and PID2019-108322GB-100), “Fundación Vencer El Cancer” (VEC), the European Regional Development Fund (FEDER), and from AGAUR to L.D.C. The Ramon y Cajal program of the Ministerio de Ciencia, Innovación y Universidades and the European Social Fund under the reference number RYC-2018-025002-I, and the Instituto de Salud Carlos III-FEDER (PI19/01814), to S.A. We acknowledge the funding support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme / Generalitat de Catalunya.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

A computational pipeline to learn gene expression predictive models from epigenetic information at enhancers or promoters

  • González Ramírez, Mar, 1991-
  • Blanco, Enrique
  • Di Croce, Luciano
Here, we present a computational pipeline to obtain quantitative models that characterize the relationship of gene expression with the epigenetic marking at enhancers or promoters in mouse embryonic stem cells. Our protocol consists of (i) generating predictive models of gene expression from epigenetic information (such as histone modification ChIP-seq) at enhancers or promoters and (ii) assessing the performance of these predictive models. This protocol could be applied to other biological scenarios or other types of epigenetic data. For complete details on the use and execution of this protocol, please refer to Gonzalez-Ramirez et al. (2021).1., The work in the Di Croce laboratory is supported by grants from “la Caixa” Foundation (HR20-00411), the Spanish Ministry of Science and Innovation (PID2019-108322GB-100), “Fundación Vencer El Cancer” (VEC), and the European Regional Development Fund (FEDER) and from AGAUR. We acknowledge support from the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, and the CERCA Programme/Generalitat de Catalunya.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis

  • Llorente, Alicia
  • Ballaré, Cecilia Julia
  • Blanco, Enrique
  • Di Croce, Luciano
  • Gomis, Roger R.
MAF amplification increases the risk of breast cancer (BCa) metastasis through mechanisms that are still poorly understood yet have important clinical implications. Oestrogen-receptor-positive (ER+) BCa requires oestrogen for both growth and metastasis, albeit by ill-known mechanisms. Here we integrate proteomics, transcriptomics, epigenomics, chromatin accessibility and functional assays from human and syngeneic mouse BCa models to show that MAF directly interacts with oestrogen receptor alpha (ERα), thereby promoting a unique chromatin landscape that favours metastatic spread. We identify metastasis-promoting genes that are de novo licensed following oestrogen exposure in a MAF-dependent manner. The histone demethylase KDM1A is key to the epigenomic remodelling that facilitates the expression of the pro-metastatic MAF/oestrogen-driven gene expression program, and loss of KDM1A activity prevents this metastasis. We have thus determined that the molecular basis underlying MAF/oestrogen-mediated metastasis requires genetic, epigenetic and hormone signals from the systemic environment, which influence the ability of BCa cells to metastasize., We also thank V. Raker for her editing support. A.L. and I.E. are supported by FPI-SO grants and A.B. and C.F.-P. by FPI Fellowship grants from Gobierno de España. M.F. is supported by the Horizon 2020 Research and Innovation Programme under Marie Skłodowska–Curie grant agreement no. 955951; M.T.B. is supported by an AECC (Spanish Cancer Association) postdoctoral grant, M.N. and R.R.G. by an AECC grant Proyecto GCTRA18006CARR. R.R.G. and L.D.C. are supported by the Institució Catalana de Recerca i Estudis Avançats. Special thanks go to Carme Segura Capellades for generously supporting our endeavours. Support and structural funds were provided by the Generalitat de Catalunya (2021-SGR-00909) to R.R.G., and by the BBVA Foundation, Fundación Científica AECC (PRYGN223207GOMI), the ISCIII/FEDER-CIBERONC, the ‘la Caixa’ Foundation (ID 100010434) under agreement HR17-00092, the FERO Foundation, the Spanish Ministerio de Economia y Competitividad (MINECO) and FEDER funds (CIBERONC and PID2019-104948RB-I00; PID2022-143093OB-100) to R.R.G. Work in the L.D.C. laboratory is supported by grants from the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) (PID2019-108322GB-100) and from AGAUR. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Herpes simplex virus type 1 reshapes host chromatin architecture via transcription machinery hijacking

  • González-Almela, Esther
  • Castells García, Àlvaro, 1991-
  • Le Dily, François
  • Fernández Merino, Manuel
  • Carnevali, Davide
  • Cuscó Pons, Pol, 1987-
  • Di Croce, Luciano
  • Cosma, Maria Pia
Herpes simplex virus type 1 (HSV-1) remodels the host chromatin structure and induces a host-to-virus transcriptional switch during lytic infection. We combine super-resolution imaging and chromosome-capture technologies to identify the mechanism of remodeling. We show that the host chromatin undergoes massive condensation caused by the hijacking of RNA polymerase II (RNAP II) and topoisomerase I (TOP1). In addition, HSV-1 infection results in the rearrangement of topologically associating domains and loops, although the A/B compartments are maintained in the host. The position of viral genomes and their association with RNAP II and cohesin is determined nanometrically. We reveal specific host-HSV-1 genome interactions and enrichment of upregulated human genes in the most contacting regions. Finally, TOP1 inhibition fully blocks HSV-1 infection, suggesting possible antiviral strategies. This viral mechanism of host chromatin rewiring sheds light on the role of transcription in chromatin architecture., We acknowledge support from Innovative Team Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR110103001 to M.P.C.); Guangzhou Key Projects of Brain Science and Brain-Like Intelligence Technology (20200730009 to M.P.C.); National Natural Science Foundation of China (31971177 and 32270577 to M.P.C., 3221101299 to A.C.G.); Science and Technology Program of Guangzhou, China (202002030146 to M.P.C.); Guangdong Foreign Young Talent Program (WGZJXM04 to A.C.G.); Spanish Ministry of Science and Innovation (grant no. PID2020-114080GB I00/AEI/10.13039/501100011033 and grant no. BFU2017-86760-P/AEI/FEDER, UE to M.P.C.) and an AGAUR grant from the Department of Research and Universities of Generalitat de Catalunya (2021-SGR2021-01300 to M.P.C.); Spanish Ministry of Science and Innovation to the European Molecular Biology Laboratory (EMBL) partnership (to M.P.C.); the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN?AEI /10.13039/501100011033); European Social Fund (FI_B00103 to M.F.M.). Funding for open access charge: National Natural Science Foundation of China (NSFC) grant (3221101299 to A.C.G.).; Spanish Ministry of Economy, Industry and Competitiveness (PID2019-108322GB-100 to L.D.C.).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis

  • Llorente, Alicia
  • Ballaré, Cecilia Julia
  • Blanco, Enrique
  • Di Croce, Luciano
  • Gomis, Roger R.
MAF amplification increases the risk of breast cancer (BCa) metastasis through mechanisms that are still poorly understood yet have important clinical implications. Oestrogen-receptor-positive (ER+) BCa requires oestrogen for both growth and metastasis, albeit by ill-known mechanisms. Here we integrate proteomics, transcriptomics, epigenomics, chromatin accessibility and functional assays from human and syngeneic mouse BCa models to show that MAF directly interacts with oestrogen receptor alpha (ERα), thereby promoting a unique chromatin landscape that favours metastatic spread. We identify metastasis-promoting genes that are de novo licensed following oestrogen exposure in a MAF-dependent manner. The histone demethylase KDM1A is key to the epigenomic remodelling that facilitates the expression of the pro-metastatic MAF/oestrogen-driven gene expression program, and loss of KDM1A activity prevents this metastasis. We have thus determined that the molecular basis underlying MAF/oestrogen-mediated metastasis requires genetic, epigenetic and hormone signals from the systemic environment, which influence the ability of BCa cells to metastasize., We also thank V. Raker for her editing support. A.L. and I.E. are supported by FPI-SO grants and A.B. and C.F.-P. by FPI Fellowship grants from Gobierno de España. M.F. is supported by the Horizon 2020 Research and Innovation Programme under Marie Skłodowska–Curie grant agreement no. 955951; M.T.B. is supported by an AECC (Spanish Cancer Association) postdoctoral grant, M.N. and R.R.G. by an AECC grant Proyecto GCTRA18006CARR. R.R.G. and L.D.C. are supported by the Institució Catalana de Recerca i Estudis Avançats. Special thanks go to Carme Segura Capellades for generously supporting our endeavours. Support and structural funds were provided by the Generalitat de Catalunya (2021-SGR-00909) to R.R.G., and by the BBVA Foundation, Fundación Científica AECC (PRYGN223207GOMI), the ISCIII/FEDER-CIBERONC, the ‘la Caixa’ Foundation (ID 100010434) under agreement HR17-00092, the FERO Foundation, the Spanish Ministerio de Economia y Competitividad (MINECO) and FEDER funds (CIBERONC and PID2019-104948RB-I00; PID2022-143093OB-100) to R.R.G. Work in the L.D.C. laboratory is supported by grants from the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) (PID2019-108322GB-100) and from AGAUR. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A computational pipeline to learn gene expression predictive models from epigenetic information at enhancers or promoters

  • González Ramírez, Mar, 1991-
  • Blanco, Enrique
  • Di Croce, Luciano
Here, we present a computational pipeline to obtain quantitative models that characterize the relationship of gene expression with the epigenetic marking at enhancers or promoters in mouse embryonic stem cells. Our protocol consists of (i) generating predictive models of gene expression from epigenetic information (such as histone modification ChIP-seq) at enhancers or promoters and (ii) assessing the performance of these predictive models. This protocol could be applied to other biological scenarios or other types of epigenetic data. For complete details on the use and execution of this protocol, please refer to Gonzalez-Ramirez et al. (2021).1., The work in the Di Croce laboratory is supported by grants from “la Caixa” Foundation (HR20-00411), the Spanish Ministry of Science and Innovation (PID2019-108322GB-100), “Fundación Vencer El Cancer” (VEC), and the European Regional Development Fund (FEDER) and from AGAUR. We acknowledge support from the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, and the CERCA Programme/Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

SpikChIP: a novel computational methodology to compare multiple ChIP-seq using spike-in chromatin

  • Blanco, Enrique
  • Di Croce, Luciano
  • Aranda Aragón, Sergio
In order to evaluate cell- and disease-specific changes in the interacting strength of chromatin targets, ChIP-seq signal across multiple conditions must undergo robust normalization. However, this is not possible using the standard ChIP-seq scheme, which lacks a reference for the control of biological and experimental variabilities. While several studies have recently proposed different solutions to circumvent this problem, substantial analytical differences among methodologies could hamper the experimental reproducibility and quantitative accuracy. Here, we propose a computational method to accurately compare ChIP-seq experiments, with exogenous spike-in chromatin, across samples in a genome-wide manner by using a local regression strategy (spikChIP). In contrast to the previous methodologies, spikChIP reduces the influence of sequencing noise of spike-in material during ChIP-seq normalization, while minimizes the overcorrection of non-occupied genomic regions in the experimental ChIP-seq. We demonstrate the utility of spikChIP with both histone and non-histone chromatin protein, allowing us to monitor for experimental reproducibility and the accurate ChIP-seq comparison of distinct experimental schemes. spikChIP software is available on GitHub (https://github.com/eblancoga/spikChIP)., Spanish of Economy, Industry and Competitiveness (MEIC) (BFU2016-75008-P, and PID2019-108322GB-100), “Fundación Vencer El Cancer” (VEC), the European Regional Development Fund (FEDER), and from AGAUR to L.D.C. The Ramon y Cajal program of the Ministerio de Ciencia, Innovación y Universidades and the European Social Fund under the reference number RYC-2018-025002-I, and the Instituto de Salud Carlos III-FEDER (PI19/01814), to S.A. We acknowledge the funding support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme / Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

SMARCAD1 and TOPBP1 contribute to heterochromatin maintenance at the transition from the 2C-like to the pluripotent state

  • Sebastián Pérez, Rubén
  • Nakagawa, Shoma
  • Tu, Xiaochuan
  • Aranda Aragón, Sergio
  • Pesaresi, Martina, 1991-
  • Gómez García, Pablo
  • Alcoverro-Bertran, Marc
  • Gómez Vázquez, José Luis
  • Carnevali, Davide
  • Borràs, Eva
  • Sabidó Aguadé, Eduard, 1981-
  • Martin, Laura
  • Nissim Rafinia, Malka
  • Meshorer, Eran
  • Neguembor, Maria Victoria
  • Di Croce, Luciano
  • Cosma, Maria Pia
Chromocenters are established after the 2-cell (2C) stage during mouse embryonic development, but the factors that mediate chromocenter formation remain largely unknown. To identify regulators of 2C heterochromatin establishment, we generated an inducible system to convert embryonic stem cells (ESCs) to 2C-like cells. This conversion is marked by a global reorganization and dispersion of H3K9me3-heterochromatin foci, which are then reversibly formed upon re-entry into pluripotency. Profiling the chromatin-bound proteome (chromatome) by genome capture of ESCs transitioning to 2C-like cells, we uncover chromatin regulators involved in de novo heterochromatin formation. We identified TOPBP1 and investigated its binding partner SMARCAD1. SMARCAD1 and TOPBP1 associate with H3K9me3-heterochromatin in ESCs. Interestingly, the nuclear localization of SMARCAD1 is lost in 2C-like cells. SMARCAD1 or TOPBP1 depletion in mouse embryos lead to developmental arrest, reduction of H3K9me3 and remodeling of heterochromatin foci. Collectively, our findings contribute to comprehending the maintenance of chromocenters during early development., This work was supported by the European Union’s Horizon 2020 Research and Innovation Programme (No 686637 and No 964342 to MPC), Ministerio de Ciencia e Innovación (grant no. PID2020-114080GB I00/AEI/10.13039/501100011033 and grant no. BFU2017-86760-P/AEI/FEDER, UE to MPC), an AGAUR grant from the Departament de Recerca i Universitats de la Generalitat de Catalunya (2021-SGR2021-01300 to MPC), Fundació La Marató de TV3 (202027-10 to MPC), and National Natural Science Foundation of China (No 31971177 to MPC); Spanish Ministry of Economy, Industry and Competitiveness (MEIC) (PID2019-108322GB-100 to LDC), and from AGAUR (LDC). We acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme. The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I+D+i 2013–2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF. RS-P was supported by a FI-AGAUR PhD fellowship from the Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement de la Generalitat de Catalunya and the co-finance of Fondo Social Europeo (2018FI_B_00637 and FSE). XT is supported by an FPI PhD fellowship from the Ministerio de Ciencia e Innovación (PRE2018-085107). SA is funded by the Ramon y Cajal program of the Ministerio de Ciencia, Innovación y Universidades, and the European Social Fund under the reference number RYC-2018-025002-I, and the Instituto de Salud Carlos III-FEDER (PI19/01814). LM is supported by a grant for the recruitment of early-stage research staff FI-2020 (Operational Program of Catalonia 2014–2020 CCI grant no. 2014ES05SFOP007 of the European Social Fund) and La Caixa Foundation fellowship (LCF/BQ/DR20/11790016). MP was supported by a Severo Ochoa PhD fellowship from the Subprograma Estatal de Formación del Ministerio de Economía y Competitividad (BES-2015-072802). MVN is funded by FP7/2007–2013 under an REA grant (608959) and Juan de la Cierva-Incorporación 2017.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Polycomb Factor PHF19 Controls Cell Growth and Differentiation Toward Erythroid Pathway in Chronic Myeloid Leukemia Cells

  • García-Montolio, Marc
  • Ballaré, Cecilia
  • Blanco, Enrique
  • Gutiérrez, Arantxa
  • Aranda, Sergi
  • Gomez Moruno, Antonio
Leucèmia mieloide crònica; Diferenciació eritroïdal; Polycomb, Leucemia mieloide crónica; Diferenciación eritroide; Polycomb, Chronic myeloid leukemia; Erythroid differentiation; Polycomb, Polycomb group (PcG) of proteins are a group of highly conserved epigenetic regulators involved in many biological functions, such as embryonic development, cell proliferation, and adult stem cell determination. PHD finger protein 19 (PHF19) is an associated factor of Polycomb repressor complex 2 (PRC2), often upregulated in human cancers. In particular, myeloid leukemia cell lines show increased levels of PHF19, yet little is known about its function. Here, we have characterized the role of PHF19 in myeloid leukemia cells. We demonstrated that PHF19 depletion decreases cell proliferation and promotes chronic myeloid leukemia (CML) differentiation. Mechanistically, we have shown how PHF19 regulates the proliferation of CML through a direct regulation of the cell cycle inhibitor p21. Furthermore, we observed that MTF2, a PHF19 homolog, partially compensates for PHF19 depletion in a subset of target genes, instructing specific erythroid differentiation. Taken together, our results show that PHF19 is a key transcriptional regulator for cell fate determination and could be a potential therapeutic target for myeloid leukemia treatment., This work was supported by the Di Croce Laboratory is supported by grants from the Spanish Ministry of Science and Innovation (BFU2016-75008-P and PID2019-108322GB-100), “Fundación Vencer El Cancer” (VEC), the European Regional Development Fund (FEDER), and from AGAUR (SGR 2017-2019). We acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya. PV was supported by the Fundación Científica de la Asociación Española Contra el Cáncer. SA was funded by the Ramon y Cajal program of the Ministerio de Ciencia, Innovación y Universidades, the European Social Fund under the reference number RYC-2018-025002-I, and the Instituto de Salud Carlos III-FEDER (PI19/01814).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis

  • Llorente, Alicia
  • Blasco, María Teresa
  • Espuny, Irene|||0000-0003-1906-4947
  • Guiu, Marc|||0000-0002-7083-986X
  • Ballaré, Cecilia
  • Blanco, Enrique|||0000-0001-6261-7370
  • Caballé Mestres, Adrià|||0000-0002-2388-4713
  • Bellmunt, Anna|||0000-0002-4810-3848
  • Salvador, Fernando|||0000-0002-0546-1354
  • Morales, Andrea
  • Nuñez, Marc
  • Loren, Guillem
  • Imbastari, Francesca
  • Fidalgo, Marta
  • Figueras-Puig, Cristina|||0000-0003-4457-6864
  • Gibler, Patrizia|||0000-0003-4100-4318
  • Graupera, Mariona|||0000-0003-4608-4185
  • Monteiro, Freddy|||0000-0002-9080-6715
  • Riera, Antoni|||0000-0001-7142-7675
  • Holen, Ingunn|||0000-0002-8759-6913
  • Avgustinova, Alexandra
  • Di Croce, Luciano|||0000-0003-3488-6228
  • Gomis, Roger R..|||0000-0001-6473-2858
MAF amplification increases the risk of breast cancer (BCa) metastasis through mechanisms that are still poorly understood yet have important clinical implications. Oestrogen-receptor-positive (ER) BCa requires oestrogen for both growth and metastasis, albeit by ill-known mechanisms. Here we integrate proteomics, transcriptomics, epigenomics, chromatin accessibility and functional assays from human and syngeneic mouse BCa models to show that MAF directly interacts with oestrogen receptor alpha (ERα), thereby promoting a unique chromatin landscape that favours metastatic spread. We identify metastasis-promoting genes that are de novo licensed following oestrogen exposure in a MAF-dependent manner. The histone demethylase KDM1A is key to the epigenomic remodelling that facilitates the expression of the pro-metastatic MAF/oestrogen-driven gene expression program, and loss of KDM1A activity prevents this metastasis. We have thus determined that the molecular basis underlying MAF/oestrogen-mediated metastasis requires genetic, epigenetic and hormone signals from the systemic environment, which influence the ability of BCa cells to metastasize.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Polycomb Factor PHF19 Controls Cell Growth and Differentiation Toward Erythroid Pathway in Chronic Myeloid Leukemia Cells

  • García-Montolio, Marc
  • Ballaré, Cecilia
  • Blanco, Enrique
  • Gutiérrez, Arantxa
  • Aranda, Sergi
  • Gomez Moruno, Antonio
Leucèmia mieloide crònica; Diferenciació eritroïdal; Polycomb, Leucemia mieloide crónica; Diferenciación eritroide; Polycomb, Chronic myeloid leukemia; Erythroid differentiation; Polycomb, Polycomb group (PcG) of proteins are a group of highly conserved epigenetic regulators involved in many biological functions, such as embryonic development, cell proliferation, and adult stem cell determination. PHD finger protein 19 (PHF19) is an associated factor of Polycomb repressor complex 2 (PRC2), often upregulated in human cancers. In particular, myeloid leukemia cell lines show increased levels of PHF19, yet little is known about its function. Here, we have characterized the role of PHF19 in myeloid leukemia cells. We demonstrated that PHF19 depletion decreases cell proliferation and promotes chronic myeloid leukemia (CML) differentiation. Mechanistically, we have shown how PHF19 regulates the proliferation of CML through a direct regulation of the cell cycle inhibitor p21. Furthermore, we observed that MTF2, a PHF19 homolog, partially compensates for PHF19 depletion in a subset of target genes, instructing specific erythroid differentiation. Taken together, our results show that PHF19 is a key transcriptional regulator for cell fate determination and could be a potential therapeutic target for myeloid leukemia treatment., This work was supported by the Di Croce Laboratory is supported by grants from the Spanish Ministry of Science and Innovation (BFU2016-75008-P and PID2019-108322GB-100), “Fundación Vencer El Cancer” (VEC), the European Regional Development Fund (FEDER), and from AGAUR (SGR 2017-2019). We acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya. PV was supported by the Fundación Científica de la Asociación Española Contra el Cáncer. SA was funded by the Ramon y Cajal program of the Ministerio de Ciencia, Innovación y Universidades, the European Social Fund under the reference number RYC-2018-025002-I, and the Instituto de Salud Carlos III-FEDER (PI19/01814).